Compliance updated on Jun 19, 2026 Screened by AAOIFI-Certified Shariah Advisor & Auditor

Financial data updated nightly

Laurus Labs Ltd

LAURUSLABS.NS ✓ COMPLIANT ☆ Track — members

NSE India · Healthcare · Pharmaceuticals ·

India Large Cap Analyst: HOLD

Last Close

$18.73

▼ -3.48%

Market Cap $10.12B · Vol 1.58M

Key Metrics

P/E Ratio

88.37

FWD: 66.72

Market Cap

$10.12B

Large Cap

Div Yield

0.11%

Semi-annual dividend

EPS Growth

+49.97%

YoY

RSI (14)

63.77

Momentum

Beta

0.98

vs Market

52W High

$19.60

4.60% below

52W Low

$8.62

101.71% above

Volume

1.58M

Avg 2.04M

P/B

10.11

Price-to-book

ROE

18.19%

Return on equity

Free Float

67.97%

Public shares

Shariah Compliance8 STANDARDS

✓ Yes, Laurus Labs Ltd (LAURUSLABS.NS) stock is Shariah compliant

AAOIFI—
Dow Jones Islamic (DJIM)—
FTSE Shariah—
MSCI Islamic—
S&P Shariah—
Al Rajhi—
Alinma—
Albilad—

Unlock the full Shariah report

See the verdict under each standard, the exact screening ratios, purification and zakat per share. AAOIFI-certified methodology trusted by global Islamic funds.

Which standards does LAURUSLABS.NS pass?

The full report shows the verdict under each of the 8 major Shariah standards, with the business-activity and financial-ratio screens behind every one.

Do I need to purify my investment?

Members see the purification amount per share, updated every financial period under the AAOIFI methodology.

Can I calculate zakat for my shares?

Members get zakat per share and a built-in calculator for their exact holding.

Historical Returns

-3.09%

+14.52%

+35.86%

+76.86%

YTD

+61.31%

+107.90%

+304.81%

+152.71%

Financials & Valuation

TTM · Annual

Total Revenue	$728.99M
Net Income	$95.21M
Revenue Growth (YoY)	+29.10%
Gross Margin	46.94%
Operating Margin	19.16%
Net Profit Margin	13.07%
ROE	18.19%
ROA · ROIC	11.91% · 13.19%

P/E Ratio	88.37
Forward P/E (FY1)	66.72
PEG Ratio	0.41
P/S	7.87
P/B	10.11
P/FCF	137.77
EPS Growth	+49.97%
Outstanding Shares	540.31M

Technical Indicators

50-Day SMA	$16.59
200-Day SMA	$12.58
RSI (14)	63.77
Beta	0.98
52-Week High	$19.60
52-Week Low	$8.62

Volume Today	1.58M
Avg Daily Volume (30D)	2.04M
Relative Volume	0.78x
Volatility (10D)	21.59
Volatility (30D)	30.61
Free Float	67.97%

Analyst Consensus

HOLD

Current Price $18.73

Mean Target $15.56

52W Low$8.62 52W High$19.60

Current

Target

$8.62 $19.60

Current Analyst target

-16.90% downside risk · 14 analysts

Identifiers

ExchangeNSE India

FIGIBBG001STPQX2

ISININE947Q01028

CountryIndia

Sub-IndustryPharmaceuticals (NEC)

Earnings DateOct 21, 2026

TypeStocks

Instrument TypeORD Ordinary Share

Similar Halal Stocks

LLY Eli Lilly and Co -2.39% JNJ Johnson & Johnson -0.66% ABBV Abbvie Inc -0.54% NVS Novartis AG -0.55% NOVN.S Novartis AG -1.05%

Company Profile

Laurus Labs Limited is an India-based company. The Company is a pharmaceutical manufacturing organization. It is engaged in developing and manufacturing active pharmaceutical ingredients (APIs) and intermediates. It supplies anti-retroviral APIs and intermediates. It provides contract and custom manufacturing solutions, allowing client organizations to outsource various stages of the manufacturing process. It is also engaged in development and manufacturing of animal-origin-free recombinant proteins, growth factors, and cell-culture media supplements catering to the needs of stem cells and regenerative medicine, vaccines and biological drugs, cultured meat, and cell-culture media manufacturing. It offers precision fermentation as a contract development and manufacturing organization (CDMO) service. Its service is offered to protein companies and bio-manufacturers operating across healthcare, food, nutrition, personal care, and bio-based materials markets.